Back to News

Renal trials in diabetes need a platform: time for a global approach?

This recent commentary featured in The Lancet Diabetes Endocrinal 2017 focuses on the need for coordinated efforts and a large international database of patients with diabetes and nephropathy.

It refers to ISN and its Advancing Clinical Trials group and Clinical Trial Networks who could be instrumental in achieving this objective.

Read more HERE.

Help us advance kidney health worldwide
Join the ISN
Back to News